CEACAM18

gene
On this page

Summary

CEACAM18 (CEA cell adhesion molecule 18, HGNC:31949) is a protein-coding gene on chromosome 19q13.41, encoding Cell adhesion molecule CEACAM18 (A8MTB9).

At a glance

  • Clinical variants (ClinVar): 2 total
  • MANE Select transcript: NM_001405061

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:31949
Approved symbolCEACAM18
NameCEA cell adhesion molecule 18
Location19q13.41
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000213822
Ensembl biotypeprotein_coding
Entrez729767

Gene structure

Transcript identifiers

Ensembl transcripts: 2 — 2 protein_coding

ENST00000396477, ENST00000695586

RefSeq mRNA: 1 — MANE Select: NM_001405061 NM_001405061

Canonical transcript exons

ENST00000396477 — 6 exons

ExonStartEnd
ENSE000015250865148139351481665
ENSE000015250895148033351480680
ENSE000017261215148301751483296
ENSE000017721145147853951478694
ENSE000034783375149058751491301
ENSE000036194485148498751485122

Expression profiles

Bgee: expression breadth broad, 20 present calls, max score 80.68.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0666 / max 36.5495, expressed in 10 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
1772240.066610

Top tissues by expression

129 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
duodenumUBERON:000211480.68gold quality
small intestineUBERON:000210860.94gold quality
small intestine Peyer’s patchUBERON:000345460.00gold quality
gall bladderUBERON:000211052.83gold quality
bone marrow cellCL:000209241.65gold quality
mucosa of transverse colonUBERON:000499140.97silver quality
sural nerveUBERON:001548838.33gold quality
colonic epitheliumUBERON:000039737.20gold quality
ventricular zoneUBERON:000305336.48gold quality
cortical plateUBERON:000534336.47gold quality
ganglionic eminenceUBERON:000402335.49gold quality
bone marrowUBERON:000237134.55gold quality
intestineUBERON:000016034.14gold quality
islet of LangerhansUBERON:000000634.09silver quality
skeletal muscle tissueUBERON:000113433.38gold quality
monocyteCL:000057632.48gold quality
hindlimb stylopod muscleUBERON:000425232.15gold quality
leukocyteCL:000073832.04gold quality
liverUBERON:000210730.00gold quality
stromal cell of endometriumCL:000225529.87gold quality
prefrontal cortexUBERON:000045129.21gold quality
smooth muscle tissueUBERON:000113529.21silver quality
rectumUBERON:000105228.81silver quality
bloodUBERON:000017827.70gold quality
lymph nodeUBERON:000002927.57gold quality
tonsilUBERON:000237227.05gold quality
urinary bladderUBERON:000125526.66gold quality
vermiform appendixUBERON:000115426.42gold quality
olfactory segment of nasal mucosaUBERON:000538625.89gold quality
placentaUBERON:000198725.81gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes3.49

Regulation

Is transcription factor: no

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
mus_musculusCeacam18ENSMUSG00000030472
rattus_norvegicusCeacam18ENSRNOG00000022701

Paralogs (24): CEACAM21 (ENSG00000007129), CEACAM7 (ENSG00000007306), CEACAM1 (ENSG00000079385), CEACAM6 (ENSG00000086548), CEACAM4 (ENSG00000105352), CEACAM5 (ENSG00000105388), PSG8 (ENSG00000124467), CEACAM8 (ENSG00000124469), HEPACAM (ENSG00000165478), PSG6 (ENSG00000170848), CEACAM3 (ENSG00000170956), PSG9 (ENSG00000183668), CEACAM19 (ENSG00000186567), HEPACAM2 (ENSG00000188175), PSG5 (ENSG00000204941), CEACAM16 (ENSG00000213892), VSTM5 (ENSG00000214376), PSG3 (ENSG00000221826), PSG7 (ENSG00000221878), PSG1 (ENSG00000231924), PSG2 (ENSG00000242221), PSG11 (ENSG00000243130), PSG4 (ENSG00000243137), CEACAM20 (ENSG00000273777)

Protein

Protein identifiers

Cell adhesion molecule CEACAM18A8MTB9 (reviewed: A8MTB9)

Alternative names: Carcinoembryonic antigen-related cell adhesion molecule 18

All UniProt accessions (2): A0A8Q3SHY6, A8MTB9

UniProt curated annotations — full annotation on UniProt →

Similarity. Belongs to the immunoglobulin superfamily. CEA family.

RefSeq proteins (1): NP_001391990* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR003598Ig_sub2Domain
IPR003599Ig_subDomain
IPR007110Ig-like_domDomain
IPR013783Ig-like_foldHomologous_superfamily
IPR036179Ig-like_dom_sfHomologous_superfamily
IPR052598IgSF_CEA-relatedFamily

UniProt features (14 total): glycosylation site 5, sequence variant 2, compositionally biased region 2, signal peptide 1, chain 1, disulfide bond 1, domain 1, region of interest 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-A8MTB9-F179.680.65

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Disulfide bonds (1): 255–296

Glycosylation sites (5): 270, 108, 112, 121, 162

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 10 (showing top): GOBP_HETEROPHILIC_CELL_CELL_ADHESION, GOBP_CELL_CELL_ADHESION, GSE13522_WT_VS_IFNG_KO_SKIN_UP, DESCARTES_MAIN_FETAL_INTESTINAL_EPITHELIAL_CELLS, DESCARTES_FETAL_INTESTINE_INTESTINAL_EPITHELIAL_CELLS, GOBP_CELL_ADHESION, chr19q13, GOBP_HOMOPHILIC_CELL_CELL_ADHESION, GSE27859_MACROPHAGE_VS_CD11C_INT_F480_INT_DC_UP, GSE37301_MULTIPOTENT_PROGENITOR_VS_CD4_TCELL_UP

GO Biological Process (0):

GO Molecular Function (0):

GO Cellular Component (0):

Protein interactions and networks

STRING

634 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
CEACAM18CEACAM19Q7Z692823
CEACAM18CTU1Q7Z7A3465
CEACAM18IGSF23A1L1A6389
CEACAM18TM4SF20Q53R12377
CEACAM18TGFB1P01137375
CEACAM18ZNF615Q8N8J6375
CEACAM18MINDY2Q8NBR6363
CEACAM18SIGLEC12Q96PQ1359
CEACAM18CD177Q8N6Q3350
CEACAM18KLHL29Q96CT2342
CEACAM18CEACAM20Q6UY09340
CEACAM18ZNF574Q6ZN55338
CEACAM18ITPRID2P28290336
CEACAM18TMEM130Q8N3G9330
CEACAM18ZFATQ9P243311

IntAct

0 interactions, top by confidence:

ESM2 similar proteins: A0A0B4J1G0, A0A0B4J1L0, A0A0G2KBC9, A1YIY0, A8MTB9, B6A8R8, C0HJX2, C0HJX3, E2RP87, H0VDZ8, P08637, P09326, P12314, P23505, P26151, P43626, P43627, P43628, P43631, P43632, P83555, P83556, Q01965, Q13291, Q14952, Q14953, Q14954, Q28942, Q2YHT5, Q61400, Q61450, Q640U3, Q68EV1, Q68SN8, Q6UX41, Q6UXE8, Q6UY09, Q6XJV4, Q6XPU4, Q7TST0

Diamond homologs: A8MTB9, O75871, Q14002, Q810J1, Q9D2Z1, Q9D871, A0A0B4J1L0, D3ZQE1, E9QA28, P06731, P11464, P11465, P13688, P16573, P31809, P31997, P40198, P40199, Q00887, Q00888, Q00889, Q13046, Q15238, Q16557, Q2WEN9, Q3KPI0, Q3UKK2, Q61400, Q63111, Q925P2, Q9UQ72, Q9UQ74, Q6UY09, Q90610, Q96RW7, G5EG78, P35917, P70193, Q91ZT1, Q92626

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

2 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance1
Likely benign0
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1191 predictions. Top by Δscore:

VariantEffectΔscore
19:51481391:A:AGacceptor_gain1.0000
19:51481392:G:GGacceptor_gain1.0000
19:51481392:GA:Gacceptor_gain1.0000
19:51481392:GAGTT:Gacceptor_gain1.0000
19:51483271:G:GTdonor_gain1.0000
19:51478693:GG:Gdonor_gain0.9900
19:51478694:GG:Gdonor_gain0.9900
19:51478694:GGTAA:Gdonor_loss0.9900
19:51478695:G:GAdonor_loss0.9900
19:51478695:G:GGdonor_gain0.9900
19:51478696:T:Adonor_loss0.9900
19:51480443:G:GTdonor_gain0.9900
19:51480452:GAA:Gdonor_gain0.9900
19:51480459:GCTG:Gdonor_gain0.9900
19:51480489:G:GTdonor_gain0.9900
19:51480490:A:Tdonor_gain0.9900
19:51481381:T:Aacceptor_gain0.9900
19:51481493:GTG:Gdonor_gain0.9900
19:51483011:CTACA:Cacceptor_loss0.9900
19:51483012:TACA:Tacceptor_loss0.9900
19:51483013:ACAG:Aacceptor_loss0.9900
19:51483014:CAGAT:Cacceptor_loss0.9900
19:51483015:A:Tacceptor_loss0.9900
19:51483015:AGAT:Aacceptor_gain0.9900
19:51483015:AGATG:Aacceptor_gain0.9900
19:51483016:G:Cacceptor_loss0.9900
19:51483016:GAT:Gacceptor_gain0.9900
19:51483016:GATG:Gacceptor_gain0.9900
19:51483016:GATGG:Gacceptor_gain0.9900
19:51483256:C:Gdonor_gain0.9900

AlphaMissense

2557 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
19:51483144:G:CW267C0.968
19:51483144:G:TW267C0.968
19:51483227:G:CR295P0.966
19:51481496:G:CW168C0.948
19:51481496:G:TW168C0.948
19:51481494:T:AW168R0.943
19:51481494:T:CW168R0.943
19:51483229:T:AC296S0.943
19:51483230:G:CC296S0.943
19:51483223:T:GY294D0.930
19:51483142:T:AW267R0.928
19:51483142:T:CW267R0.928
19:51483281:T:CI313T0.923
19:51483224:A:CY294S0.915
19:51483224:A:GY294C0.913
19:51480463:G:CW61C0.912
19:51480463:G:TW61C0.912
19:51483207:G:CW288C0.911
19:51483207:G:TW288C0.911
19:51483217:G:TG292C0.910
19:51483152:A:TN270I0.895
19:51480461:T:AW61R0.893
19:51480461:T:CW61R0.893
19:51483229:T:CC296R0.893
19:51481602:T:AC204S0.892
19:51481603:G:CC204S0.892
19:51483218:G:TG292V0.888
19:51481581:C:AR197S0.883
19:51481638:A:CS216R0.883
19:51481640:T:AS216R0.883

dbSNP variants (sampled 300 via entrez): RS1000199612 (19:51479735 C>G,T), RS1000484790 (19:51479940 G>A), RS1000622458 (19:51491334 A>C), RS1000624739 (19:51483195 G>A,C), RS1000717429 (19:51485517 G>T), RS1000758566 (19:51491063 G>A,C), RS1001205479 (19:51481106 T>C), RS1001318121 (19:51486735 T>A), RS1001745865 (19:51478937 C>T), RS1002003945 (19:51483765 A>G), RS1002056985 (19:51483919 G>A), RS1002142677 (19:51489148 C>T), RS1002453118 (19:51482390 C>T), RS1002484456 (19:51482646 A>G), RS1002873125 (19:51490029 C>T)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

3 total (human), top 3 by PubMed support.

ChemicalActions (top 5)PubMed papers
bisphenol Aaffects cotreatment, increases methylation1
Fulvestrantaffects cotreatment, increases methylation1
Benzo(a)pyreneincreases methylation1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.